InvestSMART

Atlas Arteria (ASX:ALX)

ALERT: Price-sensitive ASX Announcement for ALX
Current share price for ALX : $5.070 0.23 (4.75%)+
Release
26 Feb 2026 8:25AM
Price at Release
$4.840
Full Release
download
Summary
Atlas Arteria reported its 2025 full year results, highlighting a significant 9.4% growth in proportional toll revenue to $2,012.3 million, with proportional EBITDA at $1,509.9 million. Despite a 39.4% decline in statutory net profit after tax to $181.8 million, impacted by the Temporary Supplemental Tax (TST), the company maintained a strong operational performance. Operating free cash flow per security was 34.9 cents. Key achievements included appointing new CEOs at Dulles Greenway and Chicago Skyway, filing a rate case application at Dulles Greenway, and pursuing growth projects in France. The 2025 distribution guidance was reaffirmed at 40.0 cps, supported by a robust FX hedging program. The company focuses on long-term resilience, optimizing current businesses and exploring new growth opportunities in OECD markets.
Key Points
  • Proportional toll revenue grew by 9.4% in 2025.
  • Proportional EBITDA reached $1,509.9 million.
  • Statutory net profit after tax was $181.8 million, impacted by TST.
  • Operating free cash flow per security was 34.9 cps.
  • 2025 distribution guidance reaffirmed at 40.0 cps.
  • New CEOs appointed at Dulles Greenway and Chicago Skyway.
  • Dulles Greenway traffic increased by 8.2%.
  • Growth projects in France despite political challenges.
  • FX hedging program implemented for distribution support.
  • Focus on resilience and new opportunities in OECD markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.